How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies

Programmed death ligand-1 (PD-L1) expression is a key biomarker to screen patients for PD-1/PD-L1-targeted immunotherapy. However, a subjective assessment guide on PD-L1 expression of tumor-infiltrating immune cells (IC) scoring is currently adopted in clinical practice with low concordance. Therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinran, Wang, Liang, Bu, Hong, Zhang, Ningning, Yue, Meng, Jia, Zhanli, Cai, Lijing, He, Jiankun, Wang, Yanan, Xu, Xin, Li, Shengshui, Xiao, Kaiwen, Yan, Kezhou, Tian, Kuan, Han, Xiao, Huang, Junzhou, Yao, Jianhua, Liu, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155065/
https://www.ncbi.nlm.nih.gov/pubmed/34039982
http://dx.doi.org/10.1038/s41523-021-00268-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155065/
https://www.ncbi.nlm.nih.gov/pubmed/34039982
http://dx.doi.org/10.1038/s41523-021-00268-y

Ejemplares similares